FDA.reportPublic FDA data

Application 214650

Type
ANDA
Sponsor
MSN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFERASIROXDEFERASIROXGRANULE;ORAL180MGNoNo
002DEFERASIROXDEFERASIROXGRANULE;ORAL360MGNoNo
003DEFERASIROXDEFERASIROXGRANULE;ORAL90MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69539-199DeferasoroxDeferasiroxMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-199DeferasoroxDeferasiroxMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-200DeferasoroxDeferasiroxMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-200DeferasoroxDeferasiroxMSN LABORATORIES PRIVATE LIMITEDANDACurrent
69539-303DeferasoroxDeferasiroxMSN LABORATORIES PRIVATE LIMITEDANDACurrent
72205-075DeferasoroxDeferasiroxNovadoz Pharmaceuticals LLCANDACurrent
72205-075DeferasoroxDeferasiroxNovadoz Pharmaceuticals LLCANDACurrent
72205-076DeferasoroxDeferasiroxNovadoz Pharmaceuticals LLCANDACurrent
72205-076DeferasoroxDeferasiroxNovadoz Pharmaceuticals LLCANDACurrent
72205-176DeferasoroxDeferasiroxNovadoz Pharmaceuticals LLCANDACurrent